Tumor progression in hepatocellular carcinoma may be mediated by p53 mutation
- PMID: 8389246
Tumor progression in hepatocellular carcinoma may be mediated by p53 mutation
Abstract
Human hepatocellular carcinoma (HCC) often contains intratumoral subpopulations of heterogeneous cellular differentiations within each tumor. To analyze the genetic alterations of p53 in the heterogeneous subpopulations, we examined 68 intratumoral nodular lesions within 34 HCCs composed of two distinct subpopulations. The cellular differentiations were determined histologically by Edmondson's grading system. Nine (26.5%) of 34 HCCs examined were found to have genetic alterations in exons 5 to 8 of the p53 gene, resulting in amino acid substitutions. Three of these nine HCCs with p53 mutations showed genetic heterogeneity of the p53 gene within each tumor; one HCC had a single missense mutation at codon 210 (asparginine to 210-serine) in an intratumoral lesion of Edmondson Grade II and double missense mutations at codons 210 and 217 (asparginine to 210-serine and valine to 217-alanine) in another intratumoral lesion of Edmondson Grade III. The remaining two HCCs had p53 mutations only in lesions of a higher grade. In total, the p53 mutations were detected in none of eight Edmondson Grade I lesions, in five of 29 Grade III lesions (17.2%), in eight of 26 Grade III lesions (30.8%), and in three of five Grade IV lesions (60.0%). Thus, our data revealed that the p53 mutations were closely related to the progression of HCC and that, in certain cases, malignant cells which acquired the p53 mutations might develop into dedifferentiated subpopulations within individual HCC.
Similar articles
-
Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas.Cancer Res. 1991 Oct 15;51(20):5520-5. Cancer Res. 1991. PMID: 1655254
-
State of the p53 gene in hepatocellular carcinomas of ground squirrels and woodchucks with past and ongoing infection with hepadnaviruses.Cancer Res. 1994 Oct 15;54(20):5430-7. Cancer Res. 1994. PMID: 7923176
-
[The relation between p53 mutations and tumor invasiveness of human hepatocellular carcinoma].Zhonghua Zhong Liu Za Zhi. 1995 Nov;17(6):405-8. Zhonghua Zhong Liu Za Zhi. 1995. PMID: 8697987 Chinese.
-
p53 gene in hepatocellular carcinomas from Australia.Cancer Detect Prev. 1994;18(2):123-30. Cancer Detect Prev. 1994. PMID: 8025894 Review.
-
Mutational spectrum of the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.Drug Metab Rev. 1994;26(1-2):221-35. doi: 10.3109/03602539409029793. Drug Metab Rev. 1994. PMID: 8082567 Review. No abstract available.
Cited by
-
Frequent loss in chromosome 8p loci in liver cirrhosis accompanying hepatocellular carcinoma.J Cancer Res Clin Oncol. 1996;122(10):585-9. doi: 10.1007/BF01221189. J Cancer Res Clin Oncol. 1996. PMID: 8879255
-
Selective induction of apoptosis in Hep 3B cells by topoisomerase I inhibitors: evidence for a protease-dependent pathway that does not activate cysteine protease P32.J Clin Invest. 1996 Dec 1;98(11):2588-96. doi: 10.1172/JCI119078. J Clin Invest. 1996. PMID: 8958222 Free PMC article.
-
Deciphering Tumor Heterogeneity in Hepatocellular Carcinoma (HCC)-Multi-Omic and Singulomic Approaches.Semin Liver Dis. 2021 Jan;41(1):9-18. doi: 10.1055/s-0040-1722261. Epub 2021 Jan 14. Semin Liver Dis. 2021. PMID: 33764481 Free PMC article. Review.
-
Is p53 gene mutation an indicatior of the biological behaviors of recurrence of hepatocellular carcinoma?World J Gastroenterol. 2003 Jun;9(6):1202-7. doi: 10.3748/wjg.v9.i6.1202. World J Gastroenterol. 2003. PMID: 12800224 Free PMC article.
-
Precision medicine based on surgical oncology in the era of genome-scale analysis and genome editing technology.Ann Gastroenterol Surg. 2018 Jan 24;2(2):106-115. doi: 10.1002/ags3.12059. eCollection 2018 Mar. Ann Gastroenterol Surg. 2018. PMID: 29863171 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous